)
Mesa Laboratories (MLAB) investor relations material
Mesa Laboratories Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Biopharmaceutical development and clinical genomics performance
Biopharmaceutical development saw 17% quarterly growth, though full-year growth was 6.4% due to tariff-related shipment delays; momentum is expected to return in the second half of the year.
Clinical trial starts, a key indicator, remained flat; double-digit growth occurred in North America and Europe, but China experienced a 60% decline, impacting overall results.
Underlying growth rates are expected to improve as China headwinds subside.
Advances in clinical genomics include expanded marker panels and updated guidelines, driving market adoption and future-proofing offerings.
Increased sophistication in testing and guideline changes are supporting continued share gains and adoption.
Calibration solutions and market share
Calibration solutions achieved over 10% growth, driven mainly by volume increases in renal and biologics monitoring products.
Pricing remained steady despite inflation, with only minor creative adjustments.
Market share gains were noted in both North America and internationally, especially in dialysis machine validation.
Consumables did not experience the same pricing power as instrumentation during supply chain disruptions.
Biopharmaceutical development demand and margin dynamics
Demand in biopharmaceutical development is closely tied to clinical trials, with steady share gains over manual and semi-automated tests.
Peptide segment grew over 40% in the first half but carries lower margins; a shift back to protein analytics is expected to improve gross margins from high 50s to low 60s in the second half.
Increased clinical trial activity is anticipated to support long-term growth.
Next Mesa Laboratories earnings date
Next Mesa Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)